PRIMARY STUDY
The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism
Key Findings: A better understanding of the endocannabinoid system (ECS) and its role in Autism Spectrum Disorders (ASD) may lead to future therapeutic developments in the treatment of neurodegenerative, inflammatory, and central nervous system dysfunction.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): United States
Year of Pub: 2019
Cannabinoids Studied: Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), 2-Arachidonoyl Glycerol (2-AG), Monoacylglycerol Lipase (MAGL), Endocannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1, CB2
Route of Administration: Endogenous
Citation: Araujo DJ, et al. The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism. Front Cell Neurosci. 2019; 13:424. doi: 10.3389/fncel.2019.00424
Authors: Araujo DJ, Tjoa K, Saijo K
